These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 27531775)
1. [Analysis of the Clinical Characteristics and Prognostic Factors of 31 Cases of Primary Central Nervous System Lymphoma]. Fu L; Chen L; Wei N; Huang DY; Shen J; Wang JS; Wang YN; Cui H; Yang LZ; Wang Z Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1061-5. PubMed ID: 27531775 [TBL] [Abstract][Full Text] [Related]
2. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients]. Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435 [No Abstract] [Full Text] [Related]
3. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma]. Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773 [No Abstract] [Full Text] [Related]
4. [Primary central nervous system lymphoma--a report of 32 cases with literature review]. Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684 [TBL] [Abstract][Full Text] [Related]
5. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens]. Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248 [No Abstract] [Full Text] [Related]
6. [Clinical and prognostic analysis of 30 cases of primary central nervous system lymphoma]. She C; Tan L; Li P; Ma L; Li W Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):282-5. PubMed ID: 25916286 [TBL] [Abstract][Full Text] [Related]
7. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database]. Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634 [No Abstract] [Full Text] [Related]
8. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma]. Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019 [TBL] [Abstract][Full Text] [Related]
9. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700 [TBL] [Abstract][Full Text] [Related]
10. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma. Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738 [TBL] [Abstract][Full Text] [Related]
11. Results of primary central nervous system lymphoma treated by radiation and chemotherapy: retrospective analysis of twelve institutions in the Tokai District of Japan, 1995-1999. Kawamura T; Ishiguchi T; Shibamoto Y; Ogino H; Ishihara S; Yamada T; Katada K; Suzuki K; Suzuki H; Mimura M Radiat Med; 2006 Jan; 24(1):9-16. PubMed ID: 16715656 [TBL] [Abstract][Full Text] [Related]
12. The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma. Madle M; Krämer I; Lehners N; Schwarzbich M; Wuchter P; Herfarth K; Egerer G; Ho AD; Witzens-Harig M Ann Hematol; 2015 Nov; 94(11):1853-7. PubMed ID: 26268792 [TBL] [Abstract][Full Text] [Related]
13. Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma. Chung KM; Chang ST; Huang WT; Lu CL; Wu HC; Hwang WS; Chang KY; Chuang SS J Formos Med Assoc; 2013 Jul; 112(7):382-9. PubMed ID: 23927977 [TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological Features of Primary Central Nervous System Lymphoma and Their Influence on Prognosis of Desease]. DU CY; Yang RY; Li C; Duan LJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1776-1781. PubMed ID: 28024493 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of Clinicopathological Characteristics and Prognosis of 112 Patients with Primary Waldeyer's Ring Lymphoma]. Gao DL; Fu QQ; Zhang TT; Li SL; Pan Y; Zhai QL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1301-8. PubMed ID: 26524027 [TBL] [Abstract][Full Text] [Related]
16. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse. Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348 [TBL] [Abstract][Full Text] [Related]
17. Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee. Koh HK; Kim IH; Kim TM; Lim DH; Oh D; Cho JH; Kim WC; Kim JH; Chung WK; Jeong BK; Kang KM; Hong S; Suh CO; Kim IA J Neurooncol; 2017 Dec; 135(3):629-638. PubMed ID: 28939931 [TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma. Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566 [TBL] [Abstract][Full Text] [Related]
19. [The clinical analysis of primary central nervous system lymphoma in 23 patients]. Piao YZ; Li P; Liu Q; Li WL Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):954-7. PubMed ID: 22333130 [TBL] [Abstract][Full Text] [Related]
20. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy. Yhim HY; Kim JS; Kang HJ; Kim SJ; Kim WS; Choi CW; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Huh J; Lee DH; Suh C; Kwak JY Int J Cancer; 2012 Jul; 131(1):235-43. PubMed ID: 21823120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]